CNS-acting drugs (Morphine, Cocaine)
Start with the big picture
Morphine is obtained from the dried latex of *Papaver somniferum* capsules and is associated with opium’s characteristic brown, gummy appearance and a crimson meconic acid–ferric chloride reaction. Its action as a μ-opioid receptor agonist underlies its analgesic effects as well as important adverse effects and precautions. Cocaine comes from *Erythroxylum* leaves; identification includes microscopic features and a Thalleioquin color test. It blocks monoamine transporters and voltage-gated sodium channels, producing CNS stimulation and local anesthesia. Its therapeutic use is limited, and serious toxicities and abuse potential are central safety concerns. Together, the drugs illustrate how plant origin, chemical properties, pharmacology, and clinical risks inform pharmaceutical study.
What you'll learn
- Identify the botanical sources and key pharmacognostic features of morphine and cocaine.
- Outline the extraction and quality-assessment approaches described for each alkaloid.
- Compare the mechanisms of action and principal clinical uses of morphine and cocaine.
- Recognize major adverse effects, contraindications, toxicities, and abuse-related concerns.
- Relate selected opium alkaloids and synthetic analogs to the wider topic structure.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
